Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhalation”

17 pharma patents match "inhalation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 17
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 17 pharmaceutical patents matching "inhalation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

17 results for “inhalation” · 30,257 patents in full index Clear search

  1. US 12383516

    Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

    Amphastar Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. EP 4210672

    HYALURONSÄURE ODER SALZ DAVON ZUR INHALATION ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN UND INHALATORVORRICHTUNG DAMIT

    ALFASIGMA SPA [IT] · Granted Jul 19, 2023 · Expires Jul 14, 2043

    granted
  3. US 11357782

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  4. US 11253506

    Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  5. US 10799511

    Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  6. US 10716793

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  7. US 10695308

    Inhalation formulations of treprostinil

    United Therapeutics Corporation · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  8. US 10376525

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  9. US 10111957

    Inhalation compositions comprising glucose anhydrous

    ARVEN ILAC SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  10. US 10105316

    Inhalation compositions comprising muscarinic receptor antagonist

    ARVEN ILAC SANAYI VE TICARET A.S. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  11. US 10076505

    Inhalation formulations of Treprostinil

    United Therapeutics Corporation · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  12. US 9358240

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  13. US 9339507

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted May 17, 2016 · Expires May 12, 2036

    granted
  14. CA 2866861

    TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

    AIR LIQUIDE SANTE INT [FR] · Granted May 26, 2015 · Expires May 21, 2035

    granted
  15. US 8367734

    Stable epinephrine suspension formulation with high inhalation delivery efficiency

    Amphastar Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  16. US 6756033

    Method for delivering benzindene prostaglandins by inhalation

    United Therapeutics Corporation · Granted Jun 29, 2004 · Expires Jun 24, 2024

    expired
  17. US 6521212

    Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

    United Therapeutics Corporation · Granted Feb 18, 2003 · Expires Feb 13, 2023

    expired